Abstract
Epidemiological compartmental models, such as SEIR (Susceptible, Exposed, Infectious, and Recovered) models, have been generally used in analyzing epidemiological data and forecasting the trajectory of transmission of infectious diseases such as COVID-19. Experience shows that accurately forecasting the trajectory of COVID-19 transmission curve is a big challenge to researchers in the field of epidemiological modeling. Multiple factors (such as social distancing, vaccinations, public health interventions, and new COVID-19 variants) can affect the trajectory of COVID-19 transmission. In the past years, we used a new compartmental model, l-i SEIR model, to analyze the COVID-19 transmission trend in the United States. The letters l and i are two parameters in the model representing the average time length of the latent period and the average time length of infectious period. The l-i SEIR model takes into account of the temporal heterogeneity of infected individuals and thus improves the accuracy in forecasting the trajectory of transmission of infectious diseases. This paper describes how these multiple factors mentioned above could significantly change COVID-19 transmission trends, why accurately forecasting COVID-19 transmission trend is difficult, what the strategies we have used to improve the forecast outcome, and some of successful examples that we have obtained.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email: Xiaoping.liu{at}hsc.wvu.edu
Data availability statement
All data used in this study are publicly available.
